Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Jon C. Ogg | Apr 27, 2012 at 9:15 AM EDT

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) is supposed to be acquired by a larger drug company. It is one of the…

Jon C. Ogg | Apr 26, 2012 at 11:13 AM EDT

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

How many DJIA components can raise their dividend in one week? Johnson & Johnson (NYSE: JNJ) answered that question as…

Jon C. Ogg | Apr 23, 2012 at 2:54 PM EDT

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Ardea Biosciences, Inc. (NASDAQ: RDEA) is soaring today on news that AstraZeneca PLC (NYSE: AZN) is paying about $1.26 billion to…

Paul Ausick | Apr 23, 2012 at 7:59 AM EDT

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Diabetes drug maker Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) has hired bankers and lawyers to help the company find a buyer.…

Douglas A. McIntyre | Apr 16, 2012 at 6:34 AM EDT

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Concerns about Spain and Italy renew capital markets’ rejection of area debt. (Reuters) Best Buy (NYSE: BBY) will have to…

Paul Ausick | Mar 19, 2012 at 11:11 AM EDT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled…

Paul Ausick | Mar 6, 2012 at 8:55 AM EST

Merck Lowers First Quarter Outlook (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) this morning lowered its first quarter non-GAAP EPS estimate to $0.95-$0.98, well…

Paul Ausick | Mar 5, 2012 at 9:40 AM EST

Merck’s Ragweed Allergy Drug Results Good (MRK)

Drug maker Merck & Co. Inc. (NYSE: MRK) has released results of a phase III study of its investigational allergy…

Douglas A. McIntyre | Feb 28, 2012 at 6:11 PM EST

FDA-Use Of Statins May Cause Problems

The FDA announced today that the use of statins, common among people with high cholesterol, pose problems which were not…

Jon C. Ogg | Feb 13, 2012 at 4:17 PM EST

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. …

Paul Ausick | Feb 6, 2012 at 2:54 PM EST

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

Drug giant Merck & Co. (NYSE: MRK) plans to file this year with the US FDA for approval of the…

Paul Ausick | Feb 2, 2012 at 4:08 PM EST

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

All three major US stock indexes opened higher this morning, and spent the rest of the day bouncing around the…

Jon C. Ogg | Feb 2, 2012 at 8:55 AM EST

Merck Close to 52-Week High After Earnings (MRK)

Merck & Company, Inc. (NYSE: MRK) is trading up after its earnings report. With a high dividend yield of 4.4%,…

Jon C. Ogg | Feb 1, 2012 at 3:43 PM EST

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Earnings season is still upon us. There are going to be many big earnings reports Thursday and we would consider…

Jon C. Ogg | Jan 31, 2012 at 7:17 AM EST

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

Pfizer, Inc. (NYSE: PFE) looks good on the surface on its earnings report for the fourth quarter, but the company’s…

1 … 56 57 58 59 60 … 72

Merck : MRK

All Merck Articles

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

FDA-Use Of Statins May Cause Problems

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

Merck Close to 52-Week High After Earnings (MRK)

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Merck : MRK

All Merck Articles

One Big Disbelief of an Amylin Buyout… Worth Only $12 Per Share? (AMLN, BMY, MRK, AZN, SNY, PFE, NVO)

J&J Joins Dividend Hike One-Up Game (JNJ, PFE, MRK)

What’s A Better Buyout: Ardea or Amylin? (RDEA, AMLN, AZN, BMY, MRK)

Amylin Seeks a Buyer (AMLN, CS, GS, BMY, SNY, LLY, AZN, MRK)

Media Digest (4/16/2012) Reuters, WSJ, NYT, FT

Biopharma Firm Crushed by Merck Deal Cancellation (CRME, MRK)

Merck Lowers First Quarter Outlook (MRK)

Merck’s Ragweed Allergy Drug Results Good (MRK)

FDA-Use Of Statins May Cause Problems

Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)

Merck Will Seek FDA Approval for Insomnia Drug (MRK)

24/7 Wall St. Closing Bell (DELL, EW, AKS, STLD, BRCM, GMCR, EDMC, NDAQ, QCOM, BZH, BSX, BCO, DO, LEA, MRK, TTWO, VIAB, ZNGA, MNOV, RGDX, BIOS, URG)

Merck Close to 52-Week High After Earnings (MRK)

Top Earnings Previews For Thursday (BZH, PHM, BX, CME, DOW, GNW, GILD, IP, K, MA, MRK, RCL, HOT, TRMB, VRTX, YRCW)

Pfizer Sneaks By Earnings Estimates (PFE, MRK)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%